Customize
Quick Links

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

Acknowledgement of Commercial Support

This activity is supported by educational grants from AbbVie, Inc., Jazz Pharmaceuticals, Inc., and Takeda Oncology.

Not an official event of the 2019 ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the Conquer Cancer Foundation.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2019
Physicians’ Education Resource ®, LLC.
All rights reserved.

ASCO: Show Me the Data®: Leveraging Evidence to Optimize Applications of Novel Therapies in AML

ASCO: Show Me the Data®: Leveraging Evidence to Optimize Applications of Novel Therapies in AML


Friday, May 31, 2019

Dinner and Registration: 6:30 PM – 7:00 PM
Program: 7:00 PM - 9:00 PM

Location
Hyatt Regency Chicago
Columbus Ballroom A-F (Gold Level, East Tower)
151 East Wacker Drive
Chicago, IL 60601

Overview

This Show Me the Data® program will cover key clinical decision points in the management of acute myeloid leukemia (AML), focusing on the frontline setting. With many advances in AML, understanding the role of recently approved strategies, such as BCL2 inhibition, IDH1/2 inhibition, and FLT3 inhibition is crucial in implementing modern therapies, both for fit patients who may be candidates for intensive chemotherapy, and for less-fit patients who may not be able to tolerate traditional treatment regimens. Integrating currently available treatments and looking toward the future will enable participants in this program to update their practice patterns through a case-based program with comprehensive data supporting each clinical decision.

Benefits of Attending

  • Update your practice with the latest the clinical insights of experts in management of specific patient cases in a format that highlights clinical data supporting decisions
  • Learn the best approaches for management of patients with AML by risk categorization group, mutational status (eg, IDH1/2, FLT3), comorbidities, and prior therapies used
  • Through case-based learning and in-depth review of clinical trial results, learn the best practices in both frontline and relapsed/refractory AML management
  • See how top experts in the field develop appropriate treatment plans for a variety of patients in a unique, collaborative format that incorporates data from the latest trials and current clinical best practices

Acknowledgment of Commercial Support

This activity is supported by educational grants from AbbVie, Inc., Jazz Pharmaceuticals, Inc., and Takeda Oncology.

Not an official event of the 2019 ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the Conquer Cancer Foundation.

Target Audience

This educational program is directed toward all attendees of the 2019 ASCO Annual Meeting, including medical oncologists and hematologists interested in the treatment of AML. Nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with AML will be invited to participate.

Educational Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Identify latest best practices for testing strategies and risk stratification for patients with AML
  • Describe safety and efficacy data from the latest clinical trials with recently approved and emerging treatment options across the continuum of care in AML
  • Integrate optimized treatment approaches for AML, including treatment strategies indicated for elderly patients with AML
  • Define strategies for proactive identification and management of treatment-related toxicities for patients with AML

Program Chair

Naval G. DaverNaval G. Daver, MD
Associate Professor
Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Click to see all our ASCO programs!

Registration

2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
 
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.    

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.



Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit






Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
   1234
567891011
12131415161718
19202122232425
262728293031
Filter By